Department of Medicine, Université de Montréal and Centre hospitalier de l’Université de Montréal (CHUM)—Technopôle Angus, Montreal, QC, Canada.
Purinergic Signal. 2008 Jun;4(2):183-91. doi: 10.1007/s11302-007-9057-z. Epub 2007 Jun 30.
Previously, we observed that sustained activation of P2Y₁ leads to inhibition of Na⁺,K⁺,Cl⁻ cotransport (NKCC) in C11 cells resembling intercalated cells from collecting ducts of the Madin-Darby canine kidney. This study examined the role of stress-activated protein kinases (SAPK) in NKCC inhibition triggered by purinergic receptors. Treatment of C11 cells with ATP led to sustained phosphorylation of SAPK such as JNK and p38. Activation of these kinases also occurred in anisomycin-treated cells. Surprisingly, we observed that compounds SP600125 and SB202190, known as potent inhibitors of JNK and p38 in cell-free systems, activated rather than inhibited phosphorylation of the kinases in C11 cells. Importantly, similarly to ATP, all the above-listed activators of JNK and p38 phosphorylation inhibited NKCC. Thus, our results suggest that activation of JNK and/or p38 contributes to NKCC suppression detected in intercalated-like cells from distal tubules after their exposure to P2Y₁ agonists.
先前,我们观察到 P2Y1 的持续激活会导致 Madin-Darby 犬肾集合管中类似于间充质细胞的 C11 细胞中 Na⁺,K⁺,Cl⁻共转运(NKCC)的抑制。本研究探讨了应激激活蛋白激酶(SAPK)在嘌呤能受体触发的 NKCC 抑制中的作用。用 ATP 处理 C11 细胞会导致 SAPK(如 JNK 和 p38)的持续磷酸化。在放线菌酮处理的细胞中也发生了这些激酶的激活。令人惊讶的是,我们观察到 SP600125 和 SB202190 这两种在细胞外系统中作为 JNK 和 p38 的有效抑制剂的化合物在 C11 细胞中反而激活了而不是抑制了激酶的磷酸化。重要的是,与 ATP 一样,所有上述 JNK 和 p38 磷酸化的激活剂均抑制了 NKCC。因此,我们的结果表明,在 P2Y1 激动剂暴露后,JNK 和/或 p38 的激活有助于检测到间充质样细胞中 NKCC 的抑制。